Coe Capital Management’s Genesco GCO Stock Holding History

Coe Capital Management’s Portfolio GCO Stock Details GCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-11,716	Closed	-$666K	–	243
2015 Q4	$666K	Buy	+11,716	New	+$678K	0.26%	117
2015 Q1	–	Sell	-26,157	Closed	-$2M	–	225
2014 Q4	$2M	Buy	+26,157	New	+$1.99M	0.64%	43

Other funds holding GCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Coe Capital Management's GCO Position: Q1 2016 in Review

Coe Capital Management sold out of Genesco (GCO) in Q1 2016, closing a stake of 11,716 shares — an estimated $666K sold.

Coe Capital Management first reported a position in GCO in Q4 2014 and held it in 2 quarters. The position peaked at $2M in Q4 2014. 173 funds tracked by Wall St. Rank hold GCO as of Q1 2016.

Coe Capital Management reported no remaining Genesco position as of Q1 2016 after selling out during the quarter.
Coe Capital Management sold 11,716 Genesco shares in Q1 2016, an estimated $666K.
Coe Capital Management first reported a position in Genesco in Q4 2014 and held it in 2 quarters.
Coe Capital Management's Genesco position peaked at $2M in Q4 2014.
173 funds tracked by Wall St. Rank held Genesco as of Q1 2016.

Based on Coe Capital Management's 13F filing for Q1 2016, filed 12 May 2016.